DOT Drug & Alcohol Training Service for Designated Employer Representatives (DERs) training is now available. - Photo: J. J. Keller

DOT Drug & Alcohol Training Service for Designated Employer Representatives (DERs) training is now available.

Photo: J. J. Keller

A carrier's program for drug and alcohol testing is one of the most intricate regulatory domains, carrying substantial potential for significant risks.

At the forefront of these risks, mandated by the DOT, is the Designated Employer Representative (DER).

To assist carriers in ensuring that their DER effectively manages a compliant drug and alcohol testing program, J. J. Keller & Associates introduced the DOT Drug & Alcohol Training Service tailored for Designated Employer Representatives (DERs).

J. J. Keller's Solution to Regulatory Challenges

This program, led by consultants, is designed to train the DER appointed by the carrier's company, ensuring they are qualified to fulfill their responsibilities as stipulated by the DOT federal regulations outlined in 49 CFR Part 40 for drug and alcohol testing.

J. J. Keller’s new training service covers:

  • Drug and alcohol regulations.
  • Testing applicability.
  • DER responsibilities.
  • Drug and Alcohol Clearinghouse tasks.
  • Testing procedures.
  • Reasonable suspicion training.
  • FMCSA test types.
  • Drug and alcohol program elements.
  • Recordkeeping.
  • Example DER scenarios.

“Unlike typical online training programs, this in-person training is customized based on a carrier’s driver population, current drug and alcohol program, past violations and other criteria,” added Nebert. “Plus, our consultants can answer specific questions throughout the training pertaining to the carrier’s needs and make sure that all of the training is understood.”

Saliva-Based Drug Testing: Is it the Right Choice for Your Fleet?

About the author
News/Media Release

News/Media Release

Staff

Our editorial staff has selected and edited this news release for clarity and brand style because we believe it is relevant to our audience.

View Bio
0 Comments